SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-024262
Filing Date
2020-11-19
Accepted
2020-11-19 20:29:28
Documents
2
Period of Report
2019-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2827
2 bcda20201119_sec16.htm EX-24 6938
  Complete submission text file 0001437749-20-024262.txt   11443
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Issuer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOCARDIA, INC. 125 SHOREWAY ROAD, SUITE B SAN CARLOS CA 94070
Business Address
GILLIS EDWARD M (Reporting) CIK: 0001241359 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38999 | Film No.: 201330251